Abstract. A series of 6-substituted purines were synthesized from commercially available 2-amino-6-chloropurine with appropriate reagents, and nine new compounds 7, 8, and 11-17 have been discovered. The compounds synthesized were identified by elemental analysis, 1 H NMR, as well as mass spectral data. All the title compounds were screened for their antifungal activities, under the method of the disc diffusion, using three species of fungi -Bacillus subtillis, Aspergillus niger, and Candida tropicalis-and some of the compounds showed promising activities.
Introduction
The purine derivatives are of great importance to chemists as well as to biologists as they have been found in a large variety of naturally occurring compounds and also in clinically useful molecules having diverse biological activities [1, 2] . Purine bases modified in the 6-position and their derivatives and analogues possess a wide range of biological properties such as antitubercular, fungicidal, antiallergic, antimicrobial, antitumor, antihistamic, myocardium inhibiting agent, etc [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] .
Encouraged by the above reports and as a part of a research program on the synthesis of some biologically active heterocyclic compounds containing nitrogen, it was planned to synthesize some new 6-substituted purine derivatives carrying 2-amino-6-chloropurine, aiming at an investigation of the new heterocycles of enhanced biological activities. The present study describes the synthesis of a variety of 6-substituted purines including some unreported heterocycles of interest as imaging agent precursors for radiolabeling and unlabeled standard samples and an evaluation of their antifungal activities.
Results and Discussion
The two key intermediates 2-fluoro-6-chloropurine 3 and 2-hydroxyl-6-chloropurine 4 were synthesized by known diazotization methods [15] from commercially available 2-amino-6-chloropurine 1 (Scheme 1). The intermediate 2-amino-6-methylthiopurine 2 was prepared by the known method [16] from 1 and benzyl mercaptan, thus compound 2 reacted with four kinds of amines in the presence of DMF to form N 6 -substituted-9H-purine-2,6-diamine (5-8) according to the well established procedures [17, 18] . Among these compounds, 5 and 6 were previously reported [17, 18] , and two new compounds 7 and 8 were discovered (Scheme 2).
Our target compounds 2-amino-6-fluoropurine 9, 2-fluoro-6-fluoropurine 10 and 2-hydroxyl-6-fluoropurine 11 were prepared through chlorine-exchange fluorinations between 1 or 3 or 4 and KF by TPPB phase transfer catalysis [19] , a new com- 
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Reagents pound 11 was discovered besides the two known compounds [19] 9 and 10 (Scheme 3). The three target new compounds 2-amino-6-trifluoromethylpurine 12, 2-fluoro-6-trifluoromethylpurine 13 and 2-hydroxyl-6-trifluoromethylpurine 14 were prepared by treating 1 or 3 or 4 [20] , with sodium trifluoroacetate in DMF catalyzed by cuprous iodide at 160°C for 20 h (Scheme 3). Trifluoroethoxylation reactions of 1 or 3 or 4 to synthesize the other three new target compounds 2-amino-6-trifluoroethylpurine 15, 2-fluoro-6-trifluoroethylpurine 16 and 2-hydroxyl-6-trifluoroethylpurine 17 were carried out with sodium trifluoroethylate in DMSO under the cuprous iodide catalysis (Scheme 3) according to the well established procedures described in previous literatures [21, 22] . All the structures of the target compounds were established on the basis of spectral data and elemental analysis (see Experimental).
Antifungal activity.
6-substituted purines synthesized were screened for their antifungal activities against three species of fungi, namely Bacillus subtillis, Aspergillus niger, and Candida tropicalis using the disc diffusion method [23, 24] . The three species of fungi were grown in YGB culture media over a 14-day incubation. The tested compounds were dissolved in 1% NaOH solution (which has no inhibitory activity) to get concentrations of 1 mg/mL solution. The fluconazole was used as standard antifungal reference. The inhibition zones of microbial growth surrounding the filter paper disc (2.5 mm) were measured in millimeters at the end of an incubation period at 30°C for 3 days. Inhibition of the organisms was evidenced by a clear zone surrounding each disk (Table 1 ). All the tested compounds showed variable activities toward the three species of fungi, some of them comparable to standard fluconazole. The results of the antifungal screening showed that compounds 5-11 and 13-17 displayed good activity against Bacillus subtillis, the compounds 6-8, 11-13 and 15-16 displayed good activity against Aspergillus niger, and compounds 7, 8, 10, 11, 13 and 6-8, 11-13 and 15-17 showed good activity against Candida tropicalis, and the compounds 7, 8, 11, 13, 15 and 16 showed fairly good activity against the three fungal strains, while the remaining compounds exhibited moderate activity when compared to fluconazole (Table 1) .
Conclusions
The successful synthesis of a series of biologically active 6-substituted purines from commercially available 2-amino-6-chloropurine and evaluation of the antifungal activities of the title compounds were reported. Thirteen derivatives were prepared and nine new ones were discovered. From the results of the antifungal screening, it can be concluded that the six new derivatives 7, 8, 11, 13, 15 and 16 were found to be active against the three fungal strains. Therefore they may be used as lead compounds for further development.
Experimental Section
All the chemicals and reagents were of analytical grade and used as obtained. 1 H NMR spectra were recorded on a Bruker 400-MHz spectrometer using DMSO-d 6 as the solvent with tetramethylsilane (TMS) as an internal standard. Melting points were recorded on Digital Melting Point Apparatus WRS-1B and are uncorrected. Mass spectra were measured on an HP1100LC (Agilent Technologies, USA). Elemental analysis was performed on a Vario EL III instrument (GmbH, Germany).
2-Amino-6-methylthiopurine 2. A mixture of compound 1 (1.7 g, 10 mmol), benzyl mercaptan (6.2 g, 50 mol) and DMF (15 mL) was stirred in 50 mL round flask at 80°C for 2 h, after cooling the reaction mixture was filtered, and the residue was dissolved in 30%NaOH (30 mL) and then was neutralized with conc. HCl. 2-Fluoro-6-chloropurine 3 and 2-hydroxyl-6-chloropurine 4. A three-necked flask was loaded with compound 1 (1.7 g, 10 mmol) and 40%HBF 4 or 50%H 2 SO 4 (40 mL). The mixture was stirred at room temperature for 30 min. After cooling down to -5°C, the solution of sodium nitrite (0.76 g, 11 mmol) in H 2 O (2 mL) was added dropwise slowly, and an evolution of nitrogen gas was observed immediately, then the reaction mixture was stirred at -10°C for 2 h, urea (0.3 g, 5 mmol) was then added to decompose the excess sodium nitrite. After which, the reaction mixture was stirred at -10 or 50°C for another 5 or 1 h. Then 50%NaOH solution was added to regulate pH value of 3~4, the solid so formed was filtered, and then was dissolved completely with NaOH solution (15%, 20 mL) and separated by silica-gel column chromatography using dichloromethanemethanol (9/1) as eluent. The solution obtained was neutralized with conc. HCl. The solid was separated out and filtered to give the corresponding product 3 or 4. General procedure for compounds 9-11. A mixture of compound 1 or 3 or 4 (10 mmol), KF (50 mmol), TPPB (0.21 g, 0.5 mmol), and sulfolane (30 mL) were stirred at 60°C for about 4 h. The mixture was filtered immediately, then the solvent was removed and the residue was washed several times with water to give 9 or 10 or 11 as yellow crystals. 
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